A collection of noninvasive devices intended to conduct electrical signals from a patient's heart, via an electrode attached to the surface of the chest/limbs, to an electrocardiograph (ECG) machine or a patient monitoring system. It is designed as an insulate
| Company | Devices | Share |
|---|---|---|
| Medline Industries, Inc. | 47 | 28% |
| Renu Medical, Inc | 45 | 27% |
| Cardinal Health 200, Llc | 41 | 25% |
| Stryker Sustainability Solutions, Inc. | 33 | 20% |
Company = labeler of record on GUDID. 4 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| IKD | CABLE, ELECTRODE | 161 |
| IKD | Cable, Electrode | 70 |
Use these as the dimensions to specify in a tender line.
166 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Electrocardiographic lead set, reprocessed", from 4 companies. The largest labeler is Medline Industries, Inc. with 28% of records.
IKD (CABLE, ELECTRODE), IKD (Cable, Electrode)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add electrocardiographic lead set, reprocessed to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.